Susquehanna International Group
BIOA

Susquehanna International Group’s BioAge Labs BIOA Stock Holding History

Susquehanna International Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
+77,700
New +$1.5M ﹤0.01% 7133
2025
Q4 		– Sell
-127,800
Closed -$751K – 13864
2025
Q3 		$751K Sell
127,800
-16,600
-11% -$77.7K ﹤0.01% 8019
2025
Q2 		$596K Buy
144,400
+61,800
+75% +$249K ﹤0.01% 8776
2025
Q1 		$311K Buy
+82,600
New +$382K ﹤0.01% 10000

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Susquehanna International Group's BIOA Position: Q1 2026 in Review

Susquehanna International Group increased its BioAge Labs (BIOA) stake by 15% in Q1 2026, buying an estimated $147K and bringing the position to 60,089 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #7763.

Susquehanna International Group first reported a position in BIOA in Q1 2025 and has held it in 5 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Susquehanna International Group held 60,089 shares of BioAge Labs worth $1.05M as of Q1 2026.
  • Susquehanna International Group bought 7,650 BioAge Labs shares in Q1 2026, an estimated $147K.
  • BioAge Labs made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7763 holding.
  • Susquehanna International Group first reported a position in BioAge Labs in Q1 2025 and has held it in 5 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.